B Streptococcus (GBS) Infection Treatment Market Analysis and Future Prospects for 2030
B Streptococcus (GBS) Infection Treatment Market Analysis and Future Prospects for 2030
Source: pr-inside.com
📰 Minervax Aps News
Minervax Aps News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Minervax Aps. Real-time updates on events, politics, business and more.
MinervaX Raises EUR 54M in Upsized Financing to Advance the Development of its Maternal Vaccine Against Group B Streptococcus | Vaccines
MinervaX Raises EUR 54M in Upsized Financing to Advance the Development of its Maternal Vaccine Against Group B Streptococcus
Source: pipelinereview.com
MinervaX Announces Completion of Enrolment in Phase I Clinical Vaccine Trial as it Addresses the Global Burden of Group B Streptococcus in Older Adults
/PRNewswire/ -- MinervaX ApS, a privately held Danish biotechnology company developing a novel, prophylactic vaccine against Group B Streptococcus (GBS), has...
Lidia Oostvogels Isabel Leroux Roels Strategic Communications Lancefield Groupb Streptococcus Centre For Vaccinology Ghent University
Source: prnewswire.com
MinervaX Commences First Phase 1 Clinical Study of Novel GBS Vaccine in Older Adults
/PRNewswire/ -- MinervaX ApS, a privately held Danish biotechnology company developing a novel vaccine against Group B Streptococcus (GBS), announces the first...
Source: prnewswire.com